Evidence map›Paper›PMID 42489770›Full record

ArticleDermatology and therapy2026

Correction: Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study.

Gil Yosipovitch, Dhaval Patil, Jonathan Rodrigues, Merin Kuruvilla, Tara Raftery, Irina Pivneva, Jason Doran, Arthur Voegel, James Signorovitch, Marc A Riedl

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Gil YosipovitchUniversity of Miami, Coral Gables, FL, USA. yosipog@gmail.com.ORCID http://orcid.org/0000-0001-6303-1822
Dhaval PatilNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Jonathan RodriguesNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Merin KuruvillaNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.ORCID http://orcid.org/0000-0002-2668-4418
Tara RafteryNovartis Ireland Ltd., Dublin, Ireland.
Irina PivnevaAnalysis Group, Inc., Montréal, QC, Canada.ORCID http://orcid.org/0000-0003-1101-5200
Jason DoranAnalysis Group, Inc., Washington, DC, USA.
Arthur VoegelAnalysis Group, Inc., Montréal, QC, Canada.
James SignorovitchAnalysis Group, Inc., Boston, MA, USA.
Marc A RiedlDivision of Allergy and Immunology, Department of Medicine, University of California San Diego School of Medicine, San Diego, CA, USA.ORCID http://orcid.org/0000-0003-3460-1544

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42489770
PMCPMC13493733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.